Covaxin COVID-19 Vaccine Trial Commences in India (with Questionable Completion Targets) While New mRNA Vaccine Announced

Sponsors of the “Covaxin” COVID-19 vaccine trial in India report robust volunteer numbers as 3,500 volunteers have signed up for the clinical trial at the All India Institute of Medical Sciences (AIIMS) over the last week. Covaxin is the first vaccine developed in...

CanSino Biological, Moderna, and INOVIO Lead COVID-19 Vaccine Race; 42 Other Candidates in Pre-Clinical Stage

According to WHO, as of March 20, two vaccine candidates were in Phase I clinical trial, and 42 others were in preclinical development. This information is supplemented by an April 7, 2020 Motley Fool article with more recent developments, which is focused on vaccine...

Pin It on Pinterest